JNCCN 360 » Chronic Lymphocytic Leukemia
JNCCN 360 » Chronic Lymphocytic Leukemia
28 FOLLOWERS
This section features articles on Chronic Lymphocytic Leukemia. JNCCN 360 is a comprehensive, tumor-specific online news resource geared toward a broad audience of oncology professionals.
Understanding the ‘Black Box’ of Genetic Evolution From CLL to Richter’s Syndrome
JNCCN 360 » Chronic Lymphocytic Leukemia
by
1y ago
..read more
Visit website
Survival Outcomes of Patients With CLL and COVID-19 During Omicron Variant Dominance
JNCCN 360 » Chronic Lymphocytic Leukemia
by
1y ago
..read more
Visit website
FDA Approves Zanubrutinib in Treatment of CLL or SLL
JNCCN 360 » Chronic Lymphocytic Leukemia
by
1y ago
..read more
Visit website
ASH 2022: 4-Year Follow-up on Combination Therapy of Ibrutinib and Venetoclax in CLL
JNCCN 360 » Chronic Lymphocytic Leukemia
by
1y ago
..read more
Visit website
ASH 2022: Combination Venetoclax and Ibrutinib for High-Risk CLL
JNCCN 360 » Chronic Lymphocytic Leukemia
by
1y ago
..read more
Visit website
MRD-Driven, Time-Limited Triplet Therapy Under Study in CLL
JNCCN 360 » Chronic Lymphocytic Leukemia
by
1y ago
..read more
Visit website
Bolstering Immunity With Infection Prophylaxis in CLL
JNCCN 360 » Chronic Lymphocytic Leukemia
by
1y ago
..read more
Visit website
Membrane-Bound IL-21–Expanded NK Cells Under Study in CLL
JNCCN 360 » Chronic Lymphocytic Leukemia
by
1y ago
..read more
Visit website
SOHO 2022: Are B-Cell Receptor Stereotypes Indicative of Patient Outcomes in CLL?
JNCCN 360 » Chronic Lymphocytic Leukemia
by
1y ago
..read more
Visit website
What Is the Best Method for Assessing Splenic Volume in Patients With CLL?
JNCCN 360 » Chronic Lymphocytic Leukemia
by
1y ago
..read more
Visit website

Follow JNCCN 360 » Chronic Lymphocytic Leukemia on FeedSpot

Continue with Google
Continue with Apple
OR